Velan Capital Investment Management’s Kronos Bio KRON Stock Holding History
Bought
Maintained
Sold
Velan Capital Investment Management's KRON Position: Q2 2025 in Review
Velan Capital Investment Management sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 35,000 shares — an estimated $28.9K sold.
Velan Capital Investment Management first reported a position in KRON in Q4 2024 and held it in 2 quarters. The position peaked at $33.3K in Q4 2024. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.
- Velan Capital Investment Management reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
- Velan Capital Investment Management sold 35,000 Kronos Bio shares in Q2 2025, an estimated $28.9K.
- Velan Capital Investment Management first reported a position in Kronos Bio in Q4 2024 and held it in 2 quarters.
- Velan Capital Investment Management's Kronos Bio position peaked at $33.3K in Q4 2024.
- 0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.
Based on Velan Capital Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.